rs142054894
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 1P and 10B. PM4_SupportingBP6_ModerateBS1BS2
The NM_147686.4(TRAF3IP2):c.102_104dupACC(p.Pro35dup) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.00336 in 1,614,228 control chromosomes in the GnomAD database, including 64 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0025 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 61 hom. )
Consequence
TRAF3IP2
NM_147686.4 disruptive_inframe_insertion
NM_147686.4 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.74
Genes affected
TRAF3IP2 (HGNC:1343): (TRAF3 interacting protein 2) This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene. [provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_147686.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 6-111591982-A-AGGT is Benign according to our data. Variant chr6-111591982-A-AGGT is described in ClinVar as [Benign]. Clinvar id is 541103.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0025 (381/152338) while in subpopulation EAS AF = 0.0222 (115/5188). AF 95% confidence interval is 0.0189. There are 3 homozygotes in GnomAd4. There are 191 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00252 AC: 383AN: 152220Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
383
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00645 AC: 1620AN: 251334 AF XY: 0.00540 show subpopulations
GnomAD2 exomes
AF:
AC:
1620
AN:
251334
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00344 AC: 5036AN: 1461890Hom.: 61 Cov.: 31 AF XY: 0.00336 AC XY: 2441AN XY: 727246 show subpopulations
GnomAD4 exome
AF:
AC:
5036
AN:
1461890
Hom.:
Cov.:
31
AF XY:
AC XY:
2441
AN XY:
727246
Gnomad4 AFR exome
AF:
AC:
15
AN:
33480
Gnomad4 AMR exome
AF:
AC:
974
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
64
AN:
26136
Gnomad4 EAS exome
AF:
AC:
1543
AN:
39700
Gnomad4 SAS exome
AF:
AC:
237
AN:
86258
Gnomad4 FIN exome
AF:
AC:
1
AN:
53420
Gnomad4 NFE exome
AF:
AC:
2082
AN:
1112010
Gnomad4 Remaining exome
AF:
AC:
117
AN:
60394
Heterozygous variant carriers
0
303
606
909
1212
1515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00250 AC: 381AN: 152338Hom.: 3 Cov.: 32 AF XY: 0.00256 AC XY: 191AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
381
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
191
AN XY:
74494
Gnomad4 AFR
AF:
AC:
0.000577201
AN:
0.000577201
Gnomad4 AMR
AF:
AC:
0.00555483
AN:
0.00555483
Gnomad4 ASJ
AF:
AC:
0.00201729
AN:
0.00201729
Gnomad4 EAS
AF:
AC:
0.0221665
AN:
0.0221665
Gnomad4 SAS
AF:
AC:
0.00393538
AN:
0.00393538
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00182273
AN:
0.00182273
Gnomad4 OTH
AF:
AC:
0.00331439
AN:
0.00331439
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Candidiasis, familial, 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=64/36
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at